Alzheimers DiseaseLancet 397:1577-1590, Scheltens, P.,et al, 2021
Controversy and Progress in Alzheimers Disease - FDA Approval of AducanumabNEJM 385:doi:10.1056/NEJMp2111320, Rabinovici, G.D., 2021